Category: Medical Cannabis News

Oregon’s medical marijuana program admits to problems with MMJ oversight

Mea Culpa, this bypassed us last week. “The agency overseeing Oregon’s medical marijuana industry conceded in a report it has not provided effective oversight of growers and others in the industry, creating opportunities for cannabis to be diverted to the black market”

USA Article For Cannabis Law Report: Availability of Medical Insurance Coverage for Medical Cannabis Patients

Thankyou to Gene @ Stark & Stark and Rebecca at Greenberg Law Firm LLP for this article. With medical marijuana legal in 30 states and Washington, DC, plus the United States territories Guam and Puerto Rico and with almost two-thirds of the country having access to medical marijuana and just over 2.2 million patients nationwide, the clinical research on the health benefits and healing properties of the cannabis plant is contributing to the growing empirical studies and evidence supporting the use of marijuana as an effective medicine.

NY Dept of Health Report: Assessment Of The Potential Impact Of Regulated Marijuana In New York State

Published: July 2018, “In his January 2018 budget address, Governor Andrew M. Cuomo called for an assessment of the possible impact of regulating marijuana in New York State (NYS). The Governor directed NYS agencies to evaluate the health, public safety, and economic impact of legalizing marijuana. The experience of legalized marijuana in surrounding states was identified as an important issue to consider in the impact assessment”

The Times, They Are, A Changin’

The BBC reports, “The mother of a boy with epilepsy has legally brought medicinal cannabis oil through the UK border after being given a special licence by the government.Alfie Dingley, six, of Warwickshire, has a very rare form of the illness that causes up to 150 seizures a month”

Minnesota patients with sleep apnea now qualify for medical cannabis

Last November, the Minnesota Department of Health approved adding autism spectrum disorders and obstructive sleep apnea as qualifying conditions for the state’s medical cannabis program.

Hawaii Gov Can’t Make Decision on Medical Cannabis Vs Opioids

This appears to be dragging on according to this report on Marijuana.com

Patrick McKnight: New Jersey Opens Sixth Medical Cannabis Dispensary

The total number of enrolled patients is now more than 23,200 with 5,000 of them added this year.

Medical Wrap Up: Australia, Markets, Interview – GW Pharma

8 July 2018: Plenty of interesting things happening in the medical sphere and the injection of Canada into the fray has really upped the stakes. AUSTRALIA (i) University of Sydney – Pelican Study Cannabis & Epilepsy (ii) Medical Cannabis Favored to Treat MS Spasticity and Other Ills by Doctors in Australia, Survey Finds. MARKETS: Medicinal Marijuana’s $500m Economic ‘Blow’ For The Bahamas. INTERVIEW – GW PHARMA: Justin Gover on marketing the first cannabis-based drug.

Arkansas Looking To Launch Medical Program Early 2019

MJ Biz report… After a monthslong delay due to a court ruling, Arkansas is developing a plan that could result in the state’s medical cannabis program launching in early 2019, a state official said Tuesday.

Scott Hardin, communications director at the Arkansas Department of Finance and Administration, told Marijuana Business Daily that regulators could award five cultivation licenses as soon as July 9 and the product could be on the shelf in the first few months of 2019.

Charlotte’s Web Parent Company To Go Public

Stanley Brothers Holdings plans to go public in Canada. The firm is the parent company of CW Hemp, the manufacturer of Charlotte’s Web CBD products. This means there’s a prospectus if you’re interested in their numbers.

Australian Research On Cannabis & Chronic Pain At Odds With US Research Results

Cannabis use was common in people with chronic non-cancer pain who had been prescribed opioids, but we found no evidence that cannabis use improved patient outcomes. People who used cannabis had greater pain and lower self-efficacy in managing pain, and there was no evidence that cannabis use reduced pain severity or interference or exerted an opioid-sparing effect.

Luxembourg Says Yes To Medical Cannabis For Specific Medical Treatments

The Luxembourg government has unanimously passed the draft law to decriminalise the use of cannabis for patients suffering from diseases such as cancer, multiple sclerosis or neurodegenerative diseases.

Two Aurora Branded Medical Cannabis Products Soon To Be Available In Malta’s Pharmacies

Two products, Pedanios 22/1 and 20/1, are being shipped to Malta today (June 25th), and will become available in Maltese pharmacies shortly

The UK Independent Newspaper Reports “exceptional” Medical Cannabis Prescriptions Could Go Into Effect Within Weeks

Medical cannabis could be prescribed in exceptional cases within a fortnight. The newspaper has reported

Rite Aid Spokesperson Tells CNN They’ll Be Selling Epidiolex

Given that Epidiolex has received approval from the FDA, upon being rescheduled, Rite Aid expects to fill prescriptions for Epidiolex later this year based on availability.”

UK: GW Boss Tells Daily Mail He Wants Epidiolex On The NHS By 2019

Justin Gover, chief executive of GW Pharma, told The Mail on Sunday: ‘We hope by this time next year that Epidiolex will be approved on the NHS.’

Keep an Eye on Wednesday – GW’s Big Day With The FDA

GW Pharma, should hear from the agency by Wednesday if it receives approval for Epidiolex. It’s a sort of foregone conclusion.. but as they say, “Don’t Count Your Chickens”